Mankind Pharma Limited (BOM:543904)
India · Delayed Price · Currency is INR 2,102.75
-45.05 (-2.10%)
At close: Jan 23, 2026
Mankind Pharma Market Cap
Mankind Pharma has a market cap or net worth of 870.03 billion as of January 23, 2026. Its market cap has decreased by -28.21% in one year.
Market Cap
870.03B
Enterprise Value
921.16B
Revenue
135.46B
Ranking
n/a
PE Ratio
49.69
Stock Price
2,102.75
Market Cap Chart
Since May 9, 2023, Mankind Pharma's market cap has increased from 569.76B to 870.03B, an increase of 52.70%. That is a compound annual growth rate of 16.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 886.29B | -2.25% |
| Dec 31, 2025 | 906.73B | -23.70% |
| Dec 31, 2024 | 1.19T | 49.64% |
| Dec 29, 2023 | 794.17B | 39.39% |
| May 9, 2023 | 569.76B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Torrent Pharmaceuticals | 1.35T |
| Lupin | 977.28B |
| Dr. Reddy's Laboratories | 961.99B |
| Abbott India | 588.57B |
| GlaxoSmithKline Pharmaceuticals | 403.16B |
| J. B. Chemicals & Pharmaceuticals | 295.25B |
| AstraZeneca Pharma India | 208.68B |
| Jubilant Pharmova | 150.20B |